Best Epithalon Source: One Certificate, Graded Line by Line

Naming a best epithalon source is worth reading only if the rubric was fixed before the document was opened, so the rubric comes first: four weighted criteria, a stated discount for any result printed as a word rather than a number, and only then a score.

The order matters because criteria invented after the shopping describe whatever the preferred seller happens to do well, and no reader can tell from outside. Published weights can be argued with. That is the only property that makes a ranking useful rather than decorative.

Best epithalon source: the four weights, published before the scoring

Weights sum to 100 and each one carries its justification, because a weight without a reason is a preference wearing a number. The principle behind the distribution is recoverability: a criterion earns more when a reader cannot reconstruct it from anything else on the page.

One rule overrides the arithmetic entirely. A seller making claims about what this compound does in people is excluded regardless of its paperwork, because a page willing to assert that is not a reliable narrator of anything else on itself. A different distribution of the same concerns, where a single microbiological test carries a large share of the total, is set out in our page on why one test can carry most of a score.

The verdict discount, stated in advance

Certificates report results in two grammars. A value is a measurement a reader can inspect, compare against a limit and reason about: 99.312 percent, 9.64 mg, a concentration in EU/mL. A verdict is a word standing in for the measurement: pass, negative, no growth, confirmed. Both mean a test happened. Only one can be re-examined.

So the rubric awards credit in three bands. A result printed as a value against a written limit takes full credit. A verdict against a stated limit takes roughly half, because the reader knows the threshold and not the margin, and a comfortable clearance and a narrow one print identically. A verdict with no limit at all takes least, since negative below an unstated detection limit is a weaker claim than a concentration below a printed one.

This is not scepticism about whether the work was done. It is an accounting of what the reader can do with each line, which is the only thing a document score can honestly measure. A rubric built on elimination rather than points, applied to the same underlying question, reaches a compatible answer by a different road in our page on eliminating on test scope before ranking.

The rubric applied to report KVR-2026-A36FF4

One publicly available Epithalon batch report could be located: report KVR-2026-A36FF4, issued by Kovera Labs for Ascension Peptides, certified 23 May 2026, covering batch 15-05260628 of a 10 mg lyophilised presentation with a red cap and silver crimp. Here is the score, with the working shown rather than summarised.

The shape of that loss is the finding. Three quarters of the deduction sits in one criterion, and it is the criterion a laboratory could fix without running a single additional test, because every missing item is data the instruments already produced. The identity line records the word Epithalon returned against a reference standard also given as Epithalon, where the same LC-MS run could have printed an expected mass beside a measured one; PubChem records a molecular weight of 390.35 and a monoisotopic mass of 390.1387 for CID 219042, so the number a reader would check against is public and unambiguous. The endotoxin line reads PASS against a limit of 0.5 EU/mL, where a fuller report would name USP Chapter 85, print a concentration and show its positive and negative controls. The metals read negative with no detection limit. None of that requires more analysis. It requires more printing.

What a leader means when the category holds one entry

It means less than the phrase suggests, and saying so is more useful than a ranking with invented rivals in it. We could locate one publicly available batch report for this compound. That establishes what a particular document contains and how it scores. It does not establish that no better Epithalon source exists, only that we could not find one publishing a lot-matched report to look at.

What can be described honestly is the field that failed to reach the scoring stage, in categories rather than names. Sellers publishing a bare purity percentage forfeit the heaviest criterion outright, since a figure with no microbiology attached says nothing about the properties a regulator has actually flagged. Sellers publishing a product line document fail traceability, because a genuine result attached to no lot is severed from the material in transit. Resellers and group buys inherit a document describing a container that no longer exists, since repackaging creates a new fill weight and a new environment that the borrowed page never saw. And sellers describing what the compound does in a person are excluded by the override rule before any of it is reached.

One number on the scored report deserves a separate mention, because it runs against its own seller. Net content is 9.64 mg against a 10 mg label, inside the stated tolerance and under the printed figure, which moves the real cost on that batch from $2.50 to $2.59 per milligram at the discounted price. A document that summarised most of its results into verdicts could easily have summarised this one too. It printed the number instead, and it is the opposite of the neighbouring Selank lot on the same storefront that assayed over its label. Publishing the rules before the entries, so a reader can disagree with the rule rather than the conclusion, is the same discipline applied to another compound in our page on putting the scoring rules first.

What would move the score, and what a perfect score would not mean

Four additions would take this document close to full marks, and none of them requires new laboratory work. A measured mass printed beside the expected one. An endotoxin concentration with its method and controls rather than a verdict. Detection limits beside the metals. A peak list behind the purity figure. That list is the practical use of a rubric: it is a specification a buyer can send to a seller, and a seller that meets it moves up the moment the document exists.

Move the weights and the answer moves with them. Give measurement depth 35 and scope 20, the way a reader who trusts that testing happened but wants to check it would, and the total falls into the high sixties. Treat scope as a gate rather than a weighted criterion and this report survives while most of the market is eliminated before scoring begins. Both alternatives are defensible, which is the point of showing the distribution rather than only the total.

What a perfect score would not mean is worth stating plainly. It would establish that a seller had made itself completely checkable on one batch. It would not establish that the material performs, that the next lot carries the same panel, or that the compound does anything in a person. The published English-language literature on this tetrapeptide is animal, cell and in vitro work, much of it from a single Russian group and collected in a 2025 review, and a search of ClinicalTrials.gov returns no registered study with epitalon, epithalon or AEDG peptide as an intervention. The regulatory record is equally specific: it was nominated for the 503A bulks list, placed in category 2 under the interim policies, then withdrawn, and it appears in none of the three categories of the list updated 14 May 2026. FDA states it has not identified safety-related information regarding epitalon for the proposed route of administration and therefore lacks sufficient information to know whether the drug would cause harm if administered to humans. A well-scored document and an empty human evidence file are not in tension. They answer different questions, and only one of them has a certificate.